Francis Medical

Francis Medical Francis Medical is a dynamic medical device company committed to developing urological cancer treatment. Our Mission Is to Be:
Tough on Cancer. With U.S.

Gentle on Patients. Francis Medical develops innovative medical technologies to treat urological cancers while remaining gentle on patients. Our first product, the FDA-cleared Vanquish® Water Vapor Ablation System, uses the natural energy stored in sterile water vapor to ablate targeted prostate tissue through a minimally invasive, transurethral procedure. Our mission is personal. The company is n

amed in memory of Founder Michael Hoey’s father, Francis, who lost his life to prostate cancer in 1991. Inspired by his story, we are committed to creating technologies that help patients avoid the life-altering side effects often associated with traditional prostate cancer therapies. We believe in solutions that help patients quickly return to their normal lives. clearance achieved and international regulatory pathways underway, we are focused on bringing this breakthrough therapy to more people around the world. Follow us for updates, clinical insights, and news about our ongoing mission to improve cancer care.

06/09/2026

“Being able to now offer this as part of prostate services at UChicago Medicine is an exciting step forward for patients who are navigating their complex decision process for prostate care.”

- Abhinav Sidana, MD, University of Chicago Medicine

As Vanquish® Water V***r Ablation procedures continue to expand into clinical practice, more physicians are bringing new minimally invasive options to their patients.

Read more: tinyurl.com/VanquishInChicago

Rx Only. FDA Cleared. See francismedical.com for safety info.

06/04/2026

Progress in bringing the Vanquish® Water V***r Ablation System into routine clinical use is underscored by recent commercial adoption, including the first procedure in the Midwest, performed by Aaron Milbank, MD, of Minnesota Urology.

Following participation in the V***R 2 pivotal study, physicians are now beginning to introduce Vanquish Water V***r Ablation into routine clinical practice for appropriate patients, expanding access to a minimally invasive approach for targeted prostate tissue ablation.

“This procedure marks a critical inflection point, where clinical evidence generated by leading investigators begins to translate into real-world patient care,” said Mike Kujak, President and CEO of Francis Medical, following the recent Midwest first procedure. “We are proud to partner with experienced V***R 2 investigators as they lead the adoption of Vanquish, helping to define its role in this specialized area of urology while offering patients a minimally invasive option that preserves quality of life.”

Developed by Francis Medical, the Vanquish System delivers high-energy sterile water v***r via a transurethral approach to ablate prostate tissue.

Read more: francismedical.com/news

Rx Only. FDA Cleared. See francismedical.com for safety information.

06/02/2026

Recent commercial procedures by Dr. Neal Patel and Dr. Jason Lomboy of Advanced Urology mark the continued adoption of the Vanquish® Water V***r Ablation System in routine clinical practice.
These cases reflect the expanding use of a minimally invasive approach for targeted prostate tissue ablation.

“Early clinical data from the V***R 2 study suggests that this approach can deliver meaningful prostate tissue ablation with a favorable safety profile,” added Dr. Lomboy also of Advanced Urology. “Patients have reported minimal discomfort and high satisfaction following their procedure, reinforcing our confidence in adding this technology to our minimally invasive options in prostate care as we continue to evaluate longer-term outcomes.”
Developed by Francis Medical, the Vanquish System delivers high-energy sterile water v***r via a transurethral approach to ablate targeted prostate tissue.

Read more in the press release: www.francismedical.com/news

Rx Only. FDA Cleared. See francismedical.com for safety information.

05/28/2026

💦Full steam ahead!

The first commercial Vanquish® Water V***r Ablation procedure has been performed in Illinois, by Dr. Abhinav Sidana at UChicago Medicine, bringing a new minimally invasive option to patients in
the Chicago area.

This milestone highlights continued progress as more physicians begin integrating Vanquish into prostate care following FDA clearance.

Learn more: tinyurl.com/VanquishInChicago

Rx Only. FDA Cleared. See francismedical.com for safety info.

05/26/2026

Expanding clinical adoption is bringing the Vanquish® Water V***r Ablation System into broader practice, with Aaron Milbank, MD, of Minnesota Urology performing the first commercial (non-clinical trial) procedure in the Midwest at High Pointe Surgery Center in Lake Elmo, Minnesota, expanding access to this minimally invasive technology in the region.

“As an investigator in the V***R 2 pivotal study, I had the opportunity to evaluate Vanquish from early clinical experience,” said Dr. Milbank. “Transitioning into commercial use is a natural next step given the familiarity with both the workflow and clinical profile of the technology. Commercial adoption reflects how seamlessly Vanquish can be integrated into routine practice while maintaining a strong focus on patient safety and procedural efficiency. I look forward to continuing to evaluate outcomes and expanding access to appropriate patients.”

Developed by Francis Medical, the Vanquish System uses high-energy sterile water v***r delivered via a transurethral approach to ablate targeted prostate tissue.

Read the full press release: tinyurl.com/FirstInMidwest

Rx Only. FDA Cleared. See francismedical.com for safety information.

05/21/2026

💧 Expanding what’s possible in focal therapy.

The Vanquish® Water V***r Ablation System is able to effectively ablate in any location within the prostate, addressing a common limitation of currently available focal therapy options.

Learn about the science of water v***r: francismedical.com/science/

Rx Only. FDA Cleared. See francismedical.com for safety information.

05/19/2026

“This initial case demonstrates how seamlessly this technology can be integrated into clinical care, providing a minimally invasive option for targeted tissue ablation."
— Robert Given, MD, Urology of VA​

As the first center on the East Coast to perform Vanquish® procedures in routine commercial practice, this milestone highlights Chesapeake Regional's role in introducing new technologies into clinical practice.

Read more about Vanquish: www.francismedical.com/vanquish

Rx Only. FDA Cleared. See francismedical.com for safety information.

05/18/2026

AUA26 – Final Day Reflections

Many positive interactions on Vanquish® Water V***r Ablation in prostate tissue ablation.

Samir Taneja, MD presented initial V***R 2 Pivotal Study data at the Learning Lab.

Learn more: francismedical.com/vanquish

Rx Only. FDA Cleared. American Urological Association

05/17/2026

Reflecting on a successful AUA26 Day 2!

Arvin K. George, MD, presented initial 12-month follow-up data from the V***R 2 Pivotal Study and it was a busy day of showcasing Vanquish Water V***r Ablation for our team!

Find us: Booth 3743

Learn more: francismedical.com/vanquish

RX Only. FDA Cleared. See francismedical.com for safety information.
American Urological Association

05/16/2026

We're here!

At AUA26, visit Booth 3743 to learn about Vanquish® Water V***r Ablation or schedule a demo with our team.

Learn more: francismedical.com/vanquish

Rx Only. FDA Cleared. See francismedical.com for safety information.
American Urological Association

Address

7351 Kirkwood Lane North, Suite 130
Maple Grove, MN
55369

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17639510370

Website

Alerts

Be the first to know and let us send you an email when Francis Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Francis Medical:

Shortcuts

Share

Category